Exact Sciences Corporation

This study is testing a new blood test called Oncoguard™ Liver to see how well it can detect early-stage liver cancer in people at high risk. The test is being compared to standard ultrasound screening. Researchers are enrolling nearly 3,000 adults with cirrhosis or chronic hepat…

This study aims to gather long-term health information from people who have been prescribed the Cologuard stool test for colorectal cancer screening. It will follow 150,000 participants in the United States to see how often they get follow-up colonoscopies after a positive test a…

This study is testing whether a blood test can predict if colorectal cancer will come back after surgery. It involves 1,017 people who have had surgery for stage II or III colorectal cancer. Researchers will follow participants for up to 7 years to see if tiny amounts of cancer D…